Response to: 'Time to personalise the treatment of anti-MDA-5 associated lung disease' by Lake et al
- PMID: 29724727
- DOI: 10.1136/annrheumdis-2018-213519
Response to: 'Time to personalise the treatment of anti-MDA-5 associated lung disease' by Lake et al
Keywords: disease activity; inflammation; treatment.
Conflict of interest statement
Competing interests: None declared.
Comment on
-
2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups.Ann Rheum Dis. 2017 Dec;76(12):1955-1964. doi: 10.1136/annrheumdis-2017-211468. Epub 2017 Oct 27. Ann Rheum Dis. 2017. PMID: 29079590 Free PMC article.
-
Time to personalize the treatment of anti-MDA-5 associated lung disease.Ann Rheum Dis. 2019 Jun;78(6):e52. doi: 10.1136/annrheumdis-2018-213285. Epub 2018 Apr 11. Ann Rheum Dis. 2019. PMID: 29643107 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
